College of Life Science and Technology, Xinjiang University, Urumchi, 830046, China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.
Suzhou Center for Disease Control and Prevention, Suzhou, 215004, China.
Virol Sin. 2024 Jun;39(3):520-523. doi: 10.1016/j.virs.2024.05.003. Epub 2024 May 18.
• H1N1 strains were collected from Hunan and Jiangsu provinces in early 2023 following the optimized COVID-19 strategy. • Phylogenic analysis revealed that the epidemic H1N1 viruses fell into different HA clades compared to vaccine strains. • Mutations on HA antigenic sites suggest antigenic drift in the epidemic H1N1 viruses versus vaccine strains. • A potential mismatch was found between recommended vaccine strains and the epidemic H1N1 viruses. • The expeditious, precise, and personalized vaccine update program for influenza virus may need to be put on the agenda.
• 2023 年初,在中国优化 COVID-19 防控策略后,从湖南和江苏两省收集了 H1N1 毒株。 • 系统进化分析显示,流行的 H1N1 病毒与疫苗株相比,属于不同的 HA 分支。 • HA 抗原位点的突变表明,流行的 H1N1 病毒相对于疫苗株发生了抗原漂移。 • 推荐的疫苗株与流行的 H1N1 病毒之间存在潜在的不匹配。 • 需要将流感病毒的快速、准确和个性化疫苗更新计划提上日程。